
Alpharma Inc. (NYSE:ALO), a leading global specialty pharmaceutical company, announced that two studies to be presented this week at the American Pain Society annual meeting demonstrate the efficacy, tolerability and positive pharmacokinetic profile of Alpharma Pharmaceuticals' FLECTORŽ Patch (diclofenac epolamine topical patch) 1.
Click here for full Story http://www.medicalnewstoday.com/articles/106818.php |